Clinical Trial Update: Ketamine for the Treatment of Opioid Use Disorder and Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated ketamine for comorbid depression and opioid use disorder, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Opioid Use Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Depression, Opioid-use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-08-07